Nervous Restlessness

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AM-Pharma
AM-PharmaNetherlands - Utrecht
1 program
Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®N/A1 trial
Active Trials
NCT02651922CompletedEst. Jun 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AM-PharmaTreatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Clinical Trials (1)

NCT02651922AM-PharmaTreatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Start: Sep 2014Est. completion: Jun 2015
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space